Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 7, 2015, Pages H1207-H1217

  DiStasi, Matthew R ^a   Mund, Julie A ^a   Glenn Bohlen, H ^a   Miller, Steven J ^a   Ingram, David A ^a   Dalsing, Michael C ^a   Unthank, Joseph L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriogenesis; Collateral resistance; NADPH oxidase; Nox2; Vascular resistance

Indexed keywords

APOCYNIN; MESSENGER RNA; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ACETOPHENONE DERIVATIVE; ANTIOXIDANT; CYBB PROTEIN, MOUSE; CYTOCHROME B; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; NOX4 PROTEIN, MOUSE; P22(PHOX) PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY LIGATION; ARTERY OCCLUSION; ARTICLE; CATHETER ABLATION; COLLATERAL CIRCULATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIET INDUCED OBESITY; DISEASE ASSOCIATION; ENZYME REPRESSION; FEMORAL ARTERY LIGATION; FLOW CYTOMETRY; GENE EXPRESSION; HINDLIMB; HYPERLIPIDEMIA; LIMB PERFUSION; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERFUSION PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VASCULAR COMPENSATION IMPAIRMENT; VASCULAR RESISTANCE; ADAPTATION; ANGIOGENESIS; ANIMAL; FEMORAL ARTERY; GENETICS; LIGATION; METABOLISM; OBESITY; SURGERY; VASCULARIZATION;

ACETOPHENONES; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIOXIDANTS; COLLATERAL CIRCULATION; CYTOCHROME B GROUP; FEMORAL ARTERY; HINDLIMB; LIGATION; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; OXIDATIVE STRESS; RNA, MESSENGER;

EID: 84943166893     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00180.2015     Document Type: Article

References (100)

1. Ahimastos AA, Latouche C, Natoli AK, Reddy-luthmoodoo M, Golledge J, Kingwell BA. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication. Circ Res 114: 1144-1155, 2014.
2. Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA 309: 453-460, 2013.
3. Albadawi H, Oklu R, Cormier NR, O'Keefe RM, Heaton JT, Kobler JB, Austen WG, Watkins MT. Hind limb ischemia-reperfusion injury in diet-induced obese mice. J Surg Res 190: 683-691, 2014.
4. Annex BH. Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol 10: 387-396, 2013.
5. Aoyagi T, Higa JK, Aoyagi H, Yorichika N, Shimada B, Matsui T. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 308: H1530-H1539, 2015.
6. Baltgalvis KA, White K, Li W, Claypool MD, Lang W, Alcantara R, Singh BK, Friera AM, McLaughlin J, Hansen D, McCaughey K, Nguyen H, Smith IJ, Godinez G, Shaw SJ, Goff D, Singh R, Markovtsov V, Sun TQ, Jenkins Y, Uy G, Li Y, Pan A, Gururaja T, Lau D, Park G, Hitoshi Y, Payan DG, Kinsella TM. Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. Am J Physiol Heart Circ Physiol 306: H1128-H1145, 2014.
7. Bohlen HG. Determinants of resting and passive intestinal pressures in rat and rabbit. Am J Physiol Gastrointest Liver Physiol 253: G587-G595, 1987.
8. Bohlen HG, Gore RW, Hutchins PM. Comparison of microvascular pressures in normal and spontaneously hypertensive rats. Microvasc Res 13: 125-130, 1977.
9. Brandes RP, Schroder K. Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 19: 513-518, 2008.
10. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation 122: 1862-1875, 2010.
11. Brevetti G, Schiano V, Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis 197: 1-11, 2008.
12. Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, Quinn MT, Salaices M, Touyz RM. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J Am Soc Hypertens 5: 137-153, 2011.
13. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
14. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108: 2438-2445, 2006.
15. Cochain C, Rodero MP, Vilar J, Récalde A, Richart AL, Loinard C, Zouggari Y, Guérin C, Duriez M, Combadière B, Poupel L, Lévy BI, Mallat Z, Combadière C, Silvestre JS. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovasc Res 88: 186-195, 2010.
16. Conley JE, Kennedy WF. Collateral arterial circulation in the legs. Arch Surg 81: 348-356, 1960.
17. Csányi G, Cifuentes-Pagano E, Al Ghouleh I, Ranayhossaini DJ, Egaña L, Lopes LR, Jackson HM, Kelley EE, Pagano PJ. Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med 51: 1116-1125, 2011.
18. Dai X, Faber JE. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ Res 106: 1870-1881, 2010.
19. DeBakey ME, Lawrie GM, Glaeser DH. Patterns of atherosclerosis and their surgical significance. Ann Surg 201: 115-131, 1985.
20. Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassègue B, Griendling KK, Harrison DG, Dikalova AE. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 20: 281-294, 2013.
21. Distasi MR, Case J, Ziegler MA, Dinauer MC, Yoder MC, Haneline LS, Dalsing MC, Miller SJ, Labarrere CA, Murphy MP, Ingram DA, Unthank JL. Suppressed hindlimb perfusion in Rac2−/− and Nox2−/− mice does not result from impaired collateral growth. Am J Physiol Heart Circ Physiol 296: H877-H886, 2009.
22. Distasi MR, Unthank JL, Miller SJ. Nox2 and p47phox modulate compensatory growth of primary collateral arteries. Am J Physiol Heart Circ Physiol 306: H1435-H1443, 2014.
23. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10: 453-471, 2011.
24. Du J, Fan LM, Mai A, Li JM. Crucial roles of Nox2-derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle-aged mice. Br J Pharmacol 170: 1064-1077, 2013.
25. Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre JS. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 169: 719-728, 2006.
26. Eckstein RW, Gregg DE, Pritchard WH. The magnitude and time of development of the collateral circulation in occluded femoral, carotid, and coronary arteries. Am J Physiol 132: 351-361, 1941.
27. Estes ML, Mund JA, Ingram DA, Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. In: Current Protocols in Cytometry, edited by Robinson JP. New York: Wiley, 2010, 52: 9.33: 1-11.
28. Fadini GP, Albiero M, Vigili de Kreutzenberg S, Boscaro E, Cappellari R, Marescotti M, Poncina N, Agostini C, Avogaro A. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 36: 943-949, 2013.
29. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, Mc-Dermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382: 1329-1340, 2013.
30. Fronek K, Zweifach BW. Microvascular pressure distribution in skeletal muscle and the effect of vasodilation. Am J Physiol 228: 791-796, 1975.
31. Fung E, Helisch A. Macrophages in collateral arteriogenesis. Front Physiol 3: 353, 2012.
32. Gornik HL. Rethinking the morbidity of peripheral arterial disease and the "normal" ankle-brachial index. J Am Coll Cardiol 53: 1063-1064, 2009.
33. Gray H. Anatomy of the Human Body, edited by Lewis WH. Philadelphia, PA: Lea & Febiger, 1918.
34. Haddad P, Dussault S, Groleau J, Turgeon J, Maingrette F, Rivard A. Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells. Atherosclerosis 217: 340-349, 2011.
35. Haddad P, Dussault S, Groleau J, Turgeon J, Michaud SE, Ménard C, Perez G, Maingrette F, Rivard A. Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler Thromb Vasc Biol 29: 1522-1528, 2009.
36. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7: 681-685, 2006.
37. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schröder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
38. Heyman L, Axling U, Blanco N, Sterner O, Holm C, Berger K. Evaluation of beneficial metabolic effects of berries in high-fat fed C57BL/6J mice. J Nutr Metab 2014: 12, 2014.
39. Hoefer IE, Grundmann S, van Royen N, Voskuil M, Schirmer SH, Ulusans S, Bode C, Buschmann IR, Piek JJ. Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181: 285-293, 2005.
40. Howangyin KY, Silvestre JS. Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction. Arterioscler Thromb Vasc Biol 34: 1126-1135, 2014.
41. Ito WD, Lund N, Sager H, Becker W, Wenzel U. Differential impact of diabetes mellitus type II and arterial hypertension on collateral artery growth and concomitant macrophage accumulation. Vasa 44: 31-41, 2015.
42. Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 78: 257-264, 2008.
43. Kodama K, Toda K, Morinaga S, Yamada S, Butte AJ. Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice. Diabetes 64: 867-875, 2015.
44. Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 295: H1514-H1521, 2008.
45. Koutakis P, Weiss DJ, Miserlis D, Shostrom VK, Papoutsi E, Ha DM, Carpenter LA, McComb RD, Casale GP, Pipinos II. Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective. Redox Biol 2: 921-928, 2014.
46. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766, 1999.
47. Lash JM. Arterial and arteriolar contributions to skeletal muscle functional hyperemia in spontaneously hypertensive rats. J Appl Physiol 78: 93-100, 1995.
48. Lash JM. Contribution of arterial feed vessels to skeletal muscle functional hyperemia. J Appl Physiol 76: 1512-1519, 1994.
49. Lash JM, Nixon JC, Unthank JL. Exercise training effects on collateral and microvascular resistances in rat model of arterial insufficiency. Am J Physiol Heart Circ Physiol 268: H125-H137, 1995.
50. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53: 1925-1932, 2009.
51. Loffredo L, Carnevale R, Cangemi R, Angelico F, Augelletti T, Di Santo S, Calabrese CM, Della Volpe L, Pignatelli P, Perri L, Basili S, Violi F. NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. Int J Cardiol 165: 184-192, 2012.
52. Loffredo L, Martino F, Carnevale R, Pignatelli P, Catasca E, Perri L, Calabrese CM, Palumbo MM, Baratta F, Del Ben M, Angelico F, Violi F. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. J Pediatr 161: 1004-1009, 2012.
53. Loffredo L, Pignatelli P, Cangemi R, Andreozzi P, Panico MA, Meloni V, Violi F. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. J Vasc Surg 44: 525-530, 2006.
54. Longland CJ. The collateral circulation of the limb. Ann R Coll Surg Engl 13: 161-176, 1953.
55. Lopez JA, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD. Responsiveness of iliac collateral vessels to constrictor stimuli in atherosclerotic primates. Circ Res 63: 1020-1028, 1988.
56. Ludbrook J. Collateral artery resistance in the human lower limb. J Surg Res 6: 423-434, 1966.
57. Lynch CM, Kinzenbaw DA, Chen X, Zhan S, Mezzetti E, Filosa J, Ergul A, Faulkner JL, Faraci FM, Didion SP. Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced obesity. Stroke 44: 3195-3201, 2013.
58. McDermott M. Medications for improving walking performance in peripheral artery disease: still miles to go. JAMA 309: 487-488, 2013.
59. Miller SJ, Coppinger BJ, Zhou X, Unthank JL. Antioxidants reverse age-related collateral growth impairment. J Vasc Res 47: 108-114, 2010.
60. Miller SJ, Norton LE, Murphy MP, Dalsing MC, Unthank JL. The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat (SHR) mesenteric collateral growth impairment. Am J Physiol Heart Circ Physiol 292: H2523-H2531, 2007.
61. Morse SA, Gulati R, Reisin E. The obesity paradox and cardiovascular disease. Curr Hypertens Rep 12: 120-126, 2010.
62. Mundth ED, Darling RC, Moran JM, Buckley MJ, Linton RR, Austen WG. Quantitative correlation of distal arterial outflow and patency of femoropopliteal reversed saphenous vein grafts with intraoperative flow and pressure measurements. Surgery 65: 197-206, 1969.
63. Münzel T, Keaney JF. Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 104: 1571-1574, 2001.
64. Mykkänen OT, Huotari A, Herzig KH, Dunlop TW, Mykkänen H, Kirjavainen PV. Wild blueberries (Vaccinium myrtillus) alleviate inflammation and hypertension associated with developing obesity in mice fed with a high-fat diet. PLos One 9: e114790, 2014.
65. Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLos One 7: e46057, 2012.
66. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2− and systolic blood pressure in mice. Circ Res 89: 408-414, 2001.
67. Rocic P, Kolz C, Reed RE, Potter B, Chilian WM. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol 292: H2729-H2736, 2007.
68. Rodino-Janeiro BK, Paradela-Dobarro B, Castineiras-Landeira MI, Raposeiras-Roubin S, Gonzalez-Juanatey JR, Alvarez E. Current status of NADPH oxidase research in cardiovascular pharmacology. Vasc Health Risk Manag 9: 401-428, 2013.
69. Sanne H, Sivertsson R. The effect of exercise on the development of collateral circulation after experimental occlusion of the femoral artery in the cat. Acta Physiol Scand 73: 257-263, 1968.
70. Schoop W, Schaper W, Schaper J. Limb collaterals. In: Collateral Circulation: Heart, Brain, Kidneys, and Limbs. Boston, MA: Kluwer Academic, 1993, p. 317-327.
71. Shankar A, Li J, Nieto FJ, Klein BEK, Klein R. Association between C-reactive protein level and peripheral arterial disease among U.S. adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 154: 495-501, 2007.
72. Silver AE, Beske SD, Christou DD, Donato AJ, Moreau KL, Eskurza I, Gates PE, Seals DR. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47phox expression and evidence of endothelial oxidative stress. Circulation 115: 627-637, 2007.
73. Singer K, DelProposto J, Lee Morris D, Zamarron B, Mergian T, Maley N, Cho KW, Geletka L, Subbaiah P, Muir L, Martinez-Santibanez G, Nien-Kai Lumeng C. Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells. Mol Metab 3: 664-675, 2014.
74. Stansfield BK, Bessler WK, Mali R, Mund JA, Downing B, Li F, Sarchet KN, DiStasi MR, Conway SJ, Kapur R, Ingram DA. Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway. Hum Mol Genet 22: 977-988, 2013.
75. Sukumar P, Viswambharan H, Imrie H, Cubbon RM, Yuldasheva N, Gage M, Galloway S, Skromna A, Kandavelu P, Santos CX, Gatenby VK, Smith J, Beech DJ, Wheatcroft SB, Channon KM, Shah AM, Kearney MT. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance-Related Endothelial Cell Dysfunction. Diabetes 62: 2130-2134, 2013.
76. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and AJ mice. Metabolism 44: 645-651, 1995.
77. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111: 2347-2355, 2005.
78. Turgeon J, Haddad P, Dussault S, Groleau J, Maingrette F, Perez G, Rivard A. Protection against vascular aging in Nox2-deficient mice: Impact on endothelial progenitor cells and reparative neovascularization. Atherosclerosis 223: 122-129, 2012.
79. Tuttle JL, Hahn TL, Sanders BM, Witzmann FA, Miller SJ, Dalsing MC, Unthank JL. Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol 283: H146-H155, 2002.
80. Tuttle JL, Sanders BM, Burkhart HM, Fath SW, Herring BP, Dalsing MC, Unthank JL. Impaired collateral artery development in spontaneously hypertensive rats. Microcirculation 9: 343-351, 2002.
81. Unthank JL, Bohlen HG. Lymphatic pathways and the role of valves in lymph propulsion from small intestine. Am J Physiol Gastrointest Liver Physiol 254: G389-G398, 1988.
82. Unthank JL, McClintick JN, Labarrere CA, Li L, DiStasi MR, Miller SJ. Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysis. Physiol Rep 1: e0005, 2013.
83. Unthank JL, Nixon JC, Lash JM. Early adaptations in collateral and microvascular resistances after ligation of the rat femoral artery. J Appl Physiol 79: 73-82, 1995.
84. Urao N, Inomata H, Razvi M, Kim HW, Wary K, McKinney R, Fukai T, Ushio-Fukai M. Role of Nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res 103: 212-220, 2008.
85. Urao N, McKinney RD, Fukai T, Ushio-Fukai M. NADPH oxidase 2 regulates bone marrow microenvironment following hindlimb ischemia: role in reparative mobilization of progenitor cells. Stem Cells 30: 923-934, 2012.
86. van den Hengel LG, Hellingman AA, Nossent AY, van Oeveren-Rietdijk AM, de Vries MR, Spek CA, van Zonneveld AJ, Reitsma PH, Hamming JF, de Boer HC, Versteeg HH, Quax PHA. Proteaseactivated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. PLos One 8: e61923, 2013.
87. van Weel V, de Vries M, Voshol PJ, Verloop RE, Eilers PHC, van Hinsbergh VWM, van Bockel JH, Quax PHA. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler Thromb Vasc Biol 26: 1383-1390, 2006.
88. Varol C, Zvibel I, Spektor L, Mantelmacher FD, Vugman M, Thurm T, Khatib M, Elmaliah E, Halpern Z, Fishman S. Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation. J Immunol 193: 4002-4009, 2014.
89. Violi F, Pignatelli P, Pignata C, Plebani A, Rossi P, Sanguigni V, Carnevale R, Soresina A, Finocchi A, Cirillo E, Catasca E, Angelico F, Loffredo L. Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress. Arterioscler Thromb Vasc Biol 33: 406-412, 2013.
90. Vita JA, Holbrook M, Palmisano J, Shenouda SM, Chung WB, Hamburg NM, Eskenazi BR, Joseph L, Shapira OM. Flow-induced arterial remodeling relates to endothelial function in the human forearm. Circulation 117: 3126-3133, 2008.
91. Wang J, Peng X, Lassance-Soares R, Najafi A, Alderman L, Sood S, Xue Z, Chan R, Faber J, Epstein S, Burnett M. Aging-induced collateral dysfunction: impaired responsiveness of collaterals and susceptibility to apoptosis via dysfunctional eNOS signaling. J Cardiovasc Transl Res 4: 779-789, 2011.
92. Wind S, Beuerlein K, Armitage ME, Taye A, Kumar AHS, Janowitz D, Neff C, Shah AM, Wingler K, Schmidt HH. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56: 490-497, 2010.
93. Yan J, Tie G, Park B, Yan Y, Nowicki PT, Messina LM. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J Vasc Surg 50: 1412-1422, 2009.
94. Yang HT, Ren J, Laughlin MH, Terjung RL. Prior exercise training produces NO-dependent increases in collateral blood flow after acute arterial occlusion. Am J Physiol Heart Circ Physiol 282: H301-H310, 2002.
95. Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord 27: 1541-1545, 2003.
96. Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, Cay S, Kisacik HL, Korkmaz S. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol 97: 636-639, 2006.
97. Yun J, Rocic P, Pung YF, Belmadani S, Carrao AC, Ohanyan V, Chilian WM. Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis. Antioxid Redox Signal 11: 1961-1974, 2009.
98. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidasederived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol 295: H1008-H1016, 2008.
99. Zhou X, Bohlen HG, Unthank JL, Miller SJ. Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by NAD(P)H oxidase-derived peroxide. Am J Physiol Heart Circ Physiol 297: H2227-H2233, 2009.
100. Ziegler MA, Distasi MR, Bills RG, Miller SJ, Alloosh M, Murphy MP, George Akingba A, Sturek M, Dalsing MC, Unthank JL. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 17: 3-20, 2010.